RESEARCHER PROFILE
Sam Schulman
S
McMaster University
Sam Schulman works in Venous Thromboembolism Diagnosis and Management, Blood Coagulation and Thrombosis Mechanisms, Atrial Fibrillation Management and Outcomes, Platelet Disorders and Treatments, Hemophilia Treatment and Research. Recorded institutional associations include Sechenov University, Hamilton General Hospital, Thrombosis and Atherosclerosis Research Institute.
732Publications
60,959Citations
89H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
2005 · 5,009 citationsDefinition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
2009 · 3,756 citations2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
2024 · 3,024 citationsCOVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
2020 · 2,885 citationsPrevention of VTE in Nonsurgical Patients
2012 · 2,682 citationsDabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 · 2,583 citationsPrevention of VTE in Orthopedic Surgery Patients
2012 · 1,930 citations2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association
2022 · 1,639 citationsAmerican Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
2020 · 1,473 citationsDefinition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH
2015 · 1,419 citationsEvidence-Based Management of Anticoagulant Therapy
2012 · 1,269 citationsPerioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
2015 · 1,184 citationsTreatment and Prevention of Heparin-Induced Thrombocytopenia
2012 · 1,018 citationsExtended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism
2013 · 992 citationsA Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism
1995 · 943 citationsTreatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
2013 · 930 citationsAntithrombotic Therapy for Atrial Fibrillation
2012 · 918 citationsDirect oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials
2014 · 851 citationsHemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008 · 740 citationsIncreased fetal loss in women with heritable thrombophilia
1996 · 662 citationsThe Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism
1997 · 604 citationsPerioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant
2019 · 532 citationsCompression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial
2013 · 524 citationsHemorrhagic Complications of Anticoagulant Treatment
2004 · 515 citationsPost‐thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months
2006 · 507 citations
